Valeant Pharma (NYSE: VRX) and Salix Pharmaceuticals, Ltd. (Nasdaq: SLXP) announced that they have entered into a definitive agreement under ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Hot Corp. News Hot List Hot M&A Management Comments Mergers and Acquisitions Trader Talk

Salix Pharma (SLXP) Deal Spread Narrows as Speculators Bet on Competing BidFebruary 24, 2015 12:36 PM Valeant Pharmaceuticals (VRX) PT Lifted to $176 at Piper Jaffray; 'Neutral' MaintainedFebruary 24, 2015 9:01 AM Cantor Fitzgerald Downgrades Salix Pharmaceuticals (SLXP) to HoldFebruary 24, 2015 7:23 AM UBS Downgrades Salix Pharmaceuticals (SLXP) to NeutralFebruary 24, 2015 7:22 AM Valeant Pharmaceuticals (VRX) PT Lifted to $210 at Guggenheim Amid Salix DealFebruary 23, 2015 12:00 PM Piper Jaffray Downgrades Salix Pharmaceuticals (SLXP) to Neutral Amid TakeoverFebruary 23, 2015 6:39 AM Valeant Pharma (VRX) Nears Deal for Salix Pharma (SLXP) - CNBC's FaberFebruary 20, 2015 9:46 AM